Merck & Company, Inc. News Headlines

MRK 
$59.58
*  
0.60
1.02%
Get MRK Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    MRK After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Pershing Square takes 8.5% stake in Zoetis
12/10/2014 8:00:00 AM - Market Realist


Cramer's Mad Money - Game Over For GameStop? (12/9/14)
12/10/2014 4:45:00 AM - Seeking Alpha


Will Merck's Acquisition Of Cubist Add Shareholder Value?
12/9/2014 4:45:00 PM - Seeking Alpha


Cubist Shoots Up on $9.5 Billion Buyout Offer from Merck - Analyst Blog
12/9/2014 4:30:00 PM - Zacks.com


Merck Reaffirms Commitment to Cubist Deal Despite Patent Ruling -- Update
12/9/2014 2:06:00 PM - Dow Jones Business News


Biotech ETFs in Focus on Cubist Takeover Deal - ETF News And Commentary
12/9/2014 2:00:01 PM - Zacks.com


Dow Movers: MRK, IBM
12/9/2014 12:50:31 PM - BNK Invest


A Slight Cubist Complication
12/9/2014 11:59:00 AM - Seeking Alpha


Jim Cramer on the Stock Market: Thoughts on Merck's Deal for Cubist
12/9/2014 10:59:00 AM - TheStreet


MARKET SNAPSHOT: The S&P 500 Recorded Its Biggest Drop In Nearly 7 Weeks
12/9/2014 10:16:00 AM - Dow Jones Business News


Merck Committed To Cubist Pharma Acquisition Despite Patent Ruling
12/9/2014 9:53:00 AM - RTT News


Merck Reaffirms Commitment to Cubist Deal Despite Patent Ruling
12/9/2014 9:35:00 AM - Dow Jones Business News


Merck Statement On Cubicin Patent Litigation; Cubist Deal To Proceed As Planned
12/9/2014 8:31:00 AM - RTT News


Cramer's Mad Money - 3 Cheers For Merck (12/8/14)
12/9/2014 6:29:00 AM - Seeking Alpha


Jim Cramer's Top Stock Picks: DIS SBUX NKE ENB MRK CRZO
12/9/2014 6:00:00 AM - TheStreet


New Use For AMGN's Old Drug, BLUE In The Pink, Cellceutix Gets A Boost
12/9/2014 12:49:00 AM - RTT News


Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 6th Update
12/8/2014 10:01:00 PM - Dow Jones Business News


Jim Cramer's 'Mad Money' Recap: Why You Should Buy Disney, Starbucks, Nike Now
12/8/2014 8:34:00 PM - TheStreet


Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 5th Update
12/8/2014 6:16:00 PM - Dow Jones Business News


Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 4th Update
12/8/2014 6:06:00 PM - Dow Jones Business News


Making Money With Charles Payne: 12/8/14
12/8/2014 6:00:00 PM - Fox Business


Close Update: Stocks Turn Defensive as Energy Sector Slumps, Global Economy Wilts
12/8/2014 4:16:25 PM - MT Newswires


Health Care Sector Update for 12/08/2014: XLRN,CELG,CBST,MRK,ALR
12/8/2014 3:59:17 PM - MT Newswires


MARKET SNAPSHOT: Energy Companies Drag U.S. Stocks Lower
12/8/2014 3:47:00 PM - Dow Jones Business News


Strong Portfolio, Dividends Make Merck An Attractive Opportunity
12/8/2014 3:40:00 PM - Seeking Alpha